restricted access   Volume 2, Number 3, Summer 2002

Table of Contents

From: The American Journal of Bioethics

Previous Issue Next Issue

Conflict of Interest and AJOB

pp. 1-2

Target Article

How Can You Patent Genes?

pp. 3-11

Open Peer Commentaries

Intellectual Property and Products of Nature

pp. 12-13

Patenting Genes and the Public Interest

pp. 13-15

No Patents for Semantic Information

pp. 15-16

Waiting on Science: The Stake of Present and Future Patients

pp. 17-18

Locating Gene Patents within the Patent System

pp. 18-19

Patenting Genes? A Finger in the Dike of a Bricks-and-Mortar Patent System

p. 20
pp. 21-22

Sequence Patents Are Not the Issue

pp. 22-23

The Evolution of Gene Patenting

pp. 23-24

Patenting DNA: Who Defines and Protects the Public Good?

pp. 25-26

The Two Meanings of How and the Gene Patenting Debate

pp. 26-28

Bioterrorism and Patent Rights: "Compulsory Licensure" and the Case of Cipro

pp. 29-39

Open Peer Commentaries

Compulsory Licensure: The Case of Cipro and Beyond

p. 40

The Cipro Patent and Bioterrorism

pp. 41-42

Beyond Government Intervention: Drug Companies and Bioethics

pp. 42-43

Life, Death, and Monopoly Rights in a Democratic Society

pp. 43-44

Patents: The Public Interest versus the Private Privilege

pp. 45-46

Who Are the Guardians Guarding?

pp. 46-48

Patent Immorality?

pp. 48-49

It Is Not Unethical, Though It Is Often Unwise, to Override Patents

pp. 50-51

Not Taking, Just Borrowing: Government Use of Patented Drugs

pp. 51-52


The Gift of Life and Starfish on the Beach: The Ethics of Organ Procurement

pp. 53-56

Book Reviews

Our Posthuman Future, and: The Future Is Now: America Confronts the New Genetics, and: Redesigning Humans: Our Inevitable Genetic Future (review)

pp. 57-61

Country Doctor: A Memoir (review)

pp. 61-63

Comments on the Contested Terrain of Determining Death

pp. 63-65


pp. iii-iv